shot-button
Subscription Subscription
Home > News > World News > Article > No evidence new COVID 19 variant will impact vaccine effectiveness

'No evidence new COVID-19 variant will impact vaccine effectiveness'

Updated on: 15 December,2020 11:01 AM IST  |  Geneva
ANI |

According to the WHO official, there was no evidence to suggest that the new variant of the disease would transmit more easily or undermine vaccines against COVID-19 that are being rolled out

'No evidence new COVID-19 variant will impact vaccine effectiveness'

Photo used for representational purpose

The World Health Organisation is aware of reports that a new variant of COVID-19 has been identified in the United Kingdom, although there is no evidence to suggest that the mutation will impact the effectiveness of vaccines against the disease, WHO Health Emergencies Programme Executive Director Mike Ryan said on Monday.


UK Health Secretary Matt Hancock earlier in the day announced that a new variant of COVID-19 had been identified in the south of England, and was responsible for roughly 1,000 cases.


"We are aware of this genetic variant I think reported in about 1,000 individuals in England, and the authorities in the UK under Matt Hancock's leadership are obviously looking at the significance of this," Ryan said at a WHO virtual press briefing.


According to the WHO official, there was no evidence to suggest that the new variant of the disease would transmit more easily or undermine vaccines against COVID-19 that are being rolled out.

"Does this make this virus more serious? Does it allow the virus to transmit more easily? Does it in any way interfere with diagnostics? Would it in any way interfere with vaccine effectiveness? None of these questions have been addressed yet, and we have no information to suggest that any of that is the case," Ryan remarked.

During his appearance in parliament earlier in the day, Hancock also revealed that London will be moved into the country's highest coronavirus disease alert level tier from Wednesday, amid a surge of new cases in the UK capital.

The UK began its mass vaccination program, using a vaccine produced by Pfizer and BioNTech, this past Tuesday.

Keep scrolling to read more news

Catch up on all the latest Crime, National, International and Hatke news here. Also download the new mid-day Android and iOS apps to get latest updates.

Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK